Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (101-110 of 263) with videos related to

Pageof 27
Sort By:
Hepatology International|February 9, 2022
Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver diseaseJérémy Dana, Aïna Venkatasamy, Antonio Saviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infectionYue Wang, Naoya Kato, Yujin Hoshida, et al.
Scientific Reports|February 14, 2020
Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumptionAlyx Vogle, Tongqi Qian, Shijia Zhu, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with CirrhosisNicolas Goossens, Amit G Singal, Lindsay Y King, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulationMirko Tarocchi, Rebekka Hannivoort, Yujin Hoshida, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activationMotoyuki Otsuka, Naoya Kato, Run-Xuan Shao, et al.
World Journal of Gastroenterology|April 1, 2005
Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patientsRun-Xuan Shao, Yujin Hoshida, Motoyuki Otsuka, et al.
Frontiers in Genetics|February 20, 2018
Genomic Analysis Revealed New Oncogenic Signatures in <i>TP53</i>-Mutant Hepatocellular CarcinomaVenkatesh Kancherla, Samir Abdullazade, Matthias S Matter, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infectionYue Wang, Naoya Kato, Yujin Hoshida, et al.
Plos One|February 6, 2014
Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classificationKensuke Kojima, Craig April, Claudia Canasto-Chibuque, et al.
Pageof 27

Showing results (101-110 of 263) with videos related to

Sort By:
Pageof 27
Hepatology International|February 9, 2022
Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver diseaseJérémy Dana, Aïna Venkatasamy, Antonio Saviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infectionYue Wang, Naoya Kato, Yujin Hoshida, et al.
Scientific Reports|February 14, 2020
Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumptionAlyx Vogle, Tongqi Qian, Shijia Zhu, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with CirrhosisNicolas Goossens, Amit G Singal, Lindsay Y King, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulationMirko Tarocchi, Rebekka Hannivoort, Yujin Hoshida, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activationMotoyuki Otsuka, Naoya Kato, Run-Xuan Shao, et al.
World Journal of Gastroenterology|April 1, 2005
Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patientsRun-Xuan Shao, Yujin Hoshida, Motoyuki Otsuka, et al.
Frontiers in Genetics|February 20, 2018
Genomic Analysis Revealed New Oncogenic Signatures in <i>TP53</i>-Mutant Hepatocellular CarcinomaVenkatesh Kancherla, Samir Abdullazade, Matthias S Matter, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infectionYue Wang, Naoya Kato, Yujin Hoshida, et al.
Plos One|February 6, 2014
Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classificationKensuke Kojima, Craig April, Claudia Canasto-Chibuque, et al.
Pageof 27